MAPPING AND COMPARISON OF THE INTERACTION SITES ON THE FC REGION OF IGG RESPONSIBLE FOR TRIGGERING ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) THROUGH DIFFERENT TYPES OF HUMAN FC-GAMMA RECEPTOR

被引:94
作者
SARMAY, G
LUND, J
ROZSNYAY, Z
GERGELY, J
JEFFERIS, R
机构
[1] UNIV BIRMINGHAM, SCH MED, DEPT IMMUNOL, VINCENT DR, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND
[2] L EOTVOS UNIV, DEPT IMMUNOL, H-2131 GOD, HUNGARY
关键词
D O I
10.1016/0161-5890(92)90200-H
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study 3-iodo-4-hydroxy-5-nitrophenacetyl (NIP)-specific antibodies were compared for induction of antibody dependent lysis of NIP-derivatised red blood cells effected by pre-stimulated U937 or HL-60 cells and by K cells. The chimaeric antibodies have heavy chains corresponding to human IgG subclasses 1-4, and include site-directed mutants of IgG3 as well as the aglycosylated form of IgG3; a mouse IgG2b antibody and a site-directed mutant IgG2b were also examined. rIFN stimulated U937 or HL-60 cells express increased levels of Fc-gamma-R1 compared to unstimulated cells; PMA stimulated HL-60 and U937 cells express an increased level of Fc-gamma-R11 compared to unstimulated cells; K cells express Fc-gamma-R111. Using these effector cell populations and the target cells mentioned above, we have compared anti-NIP antibodies with different heavy chain constant domains for their ability to induce ADCC through human Fc-gamma-R1, Fc-gamma-R11 and Fc-gamma-R111. The results suggest that all three human Fc-gamma-receptors appear to recognise a binding site on IgG within the lower hinge (residues 234-237) and trigger ADCC via this site, but that each receptor sees this common site in a different way. The possibility that other amino acid residues also participate in the binding/triggering site(s) cannot be excluded.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 27 条
[1]   EPSTEIN-BARR VIRUS SUSCEPTIBILITY OF NORMAL HUMAN B-LYMPHOCYTE POPULATIONS [J].
AMAN, P ;
EHLINHENRIKSSON, B ;
KLEIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) :208-220
[2]   HUMAN-LEUKOCYTE IGG FC-RECEPTORS [J].
ANDERSON, CL ;
LOONEY, RJ .
IMMUNOLOGY TODAY, 1986, 7 (09) :264-266
[3]  
BOOT JHA, 1989, J IMMUNOL, V142, P1217
[4]  
Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7
[5]   STRUCTURE AND EXPRESSION OF HUMAN-IGG FCRII(CD32) - FUNCTIONAL-HETEROGENEITY IS ENCODED BY THE ALTERNATIVELY SPLICED PRODUCTS OF MULTIPLE GENES [J].
BROOKS, DG ;
QIU, WQ ;
LUSTER, AD ;
RAVETCH, JV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1369-1385
[6]   COMPARISON OF THE EFFECTOR FUNCTIONS OF HUMAN-IMMUNOGLOBULINS USING A MATCHED SET OF CHIMERIC ANTIBODIES [J].
BRUGGEMANN, M ;
WILLIAMS, GT ;
BINDON, CI ;
CLARK, MR ;
WALKER, MR ;
JEFFERIS, R ;
WALDMANN, H ;
NEUBERGER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1351-1361
[7]   THE HUMAN MONONUCLEAR PHAGOCYTE HIGH-AFFINITY FC RECEPTOR, FCRI, DEFINED BY A MONOCLONAL-ANTIBODY, 10.1 [J].
DOUGHERTY, GJ ;
SELVENDRAN, Y ;
MURDOCH, S ;
PALMER, DG ;
HOGG, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1453-1459
[8]   LOCALIZATION OF THE BINDING-SITE FOR THE HUMAN HIGH-AFFINITY FC RECEPTOR ON IGG [J].
DUNCAN, AR ;
WOOF, JM ;
PARTRIDGE, LJ ;
BURTON, DR ;
WINTER, G .
NATURE, 1988, 332 (6164) :563-564
[9]   BINDING CHARACTERISTICS AND ISOTYPE SPECIFICITY OF FC-RECEPTORS ON K-CELLS [J].
GERGELY, J ;
SARMAY, G ;
ROZSNYAY, Z ;
STANWORTH, DR ;
KLEIN, E .
MOLECULAR IMMUNOLOGY, 1986, 23 (11) :1203-1209
[10]  
GRAZIANO RF, 1987, J IMMUNOL, V139, P3536